Development of a Urinary Screening Method, a Urinary Quantitative Confirmatory Method and Metabolic Profiling of the Semi-Synthetic Cannabinoid Hexahydrocannabinol in Humans Using UPLC-MS-QToF and UHPLC-MS/MS
Integrating Network Pharmacology and Molecular Docking to Identify the Active Substances and Mechanisms of Chrysanthemum Against Dry Eye
